Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L DeVane

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 1995
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugsC L DeVane
NIDA Research Monograph|January 1, 1995
Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medicationsC L DeVane
The American Journal of Psychiatry|May 1, 1997
Rethinking treatment terminologyC L Devane
The Journal of Clinical Psychiatry|January 9, 1999
Differential pharmacology of newer antidepressantsC L DeVane
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2000
Interaction potential of selective serotonin-reuptake inhibitorsC L DeVane
Cellular and Molecular Neurobiology|June 24, 1999
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitorsC L DeVane
The Journal of Clinical Psychiatry|December 1, 1994
Pharmacogenetics and drug metabolism of newer antidepressant agentsC L DeVane
Clinics in Laboratory Medicine|September 1, 1987
Monitoring cyclic antidepressantsC L DeVane
Psychopharmacology Bulletin|October 26, 2002
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacologyC L DeVane, H L Liston
American Journal of Hospital Pharmacy|October 1, 1983
Estimation of half-life and exponential decay using a nomogramS W Carson, C L DeVane
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 1995
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugsC L DeVane
NIDA Research Monograph|January 1, 1995
Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medicationsC L DeVane
The American Journal of Psychiatry|May 1, 1997
Rethinking treatment terminologyC L Devane
The Journal of Clinical Psychiatry|January 9, 1999
Differential pharmacology of newer antidepressantsC L DeVane
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2000
Interaction potential of selective serotonin-reuptake inhibitorsC L DeVane
Cellular and Molecular Neurobiology|June 24, 1999
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitorsC L DeVane
The Journal of Clinical Psychiatry|December 1, 1994
Pharmacogenetics and drug metabolism of newer antidepressant agentsC L DeVane
Clinics in Laboratory Medicine|September 1, 1987
Monitoring cyclic antidepressantsC L DeVane
Psychopharmacology Bulletin|October 26, 2002
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacologyC L DeVane, H L Liston
American Journal of Hospital Pharmacy|October 1, 1983
Estimation of half-life and exponential decay using a nomogramS W Carson, C L DeVane
Pageof 13